Asthma pharmacotherapy and utilization by children in 3 managed care organizations

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 6, 2000, Pages 1108-1114

  Donahue, James G ^a   Fuhlbrigge, Anne L ^a   Finkelstein, Jonathan A ^a   Fagan, Joanne ^a   Livingston, James M ^a   Lozano, Paula ^a   Platt, Richard ^a   Weiss, Scott T ^a   Weiss, Kevin B ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

Asthma; Bronchodilators; Children; Cromolyn; Hospitalization; Inhaled corticosteroids; Practice guidelines

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL; THEOPHYLLINE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILD HOSPITALIZATION; CORTICOSTEROID THERAPY; DATA BASE; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; OUTPATIENT CARE; PRIORITY JOURNAL;

EID: 0034546355     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.111432     Document Type: Article

References (35)

1. Disabilities among children aged ≤ 17 years - United States, 1991-1992
2. An economic evaluation of asthma in the United States
3. The economic burden of asthma in US children: Estimates from the National Medical Expenditure Survey
4. Surveillance for asthma - United States, 1960-1995
5. Changing patterns of asthma mortality. Identifying target populations at high risk
6. Poverty, race, and hospitalization for childhood asthma
7. Variations in asthma hospitalizations and deaths in New York City
8. Variations in rates of hospitalization of children in three urban communities
9. Use of inhaled corticosteroids in pediatric asthma
10. Definition of pediatric asthma and associated risk factors
11. Drag utilization evaluation identifies costs associated with high use of beta-adrenergic agonists
12. Has asthma medication use in children become more frequent, more appropriate, or both?
13. Patterns of anti-inflammatory therapy in the post-guidelines era: A retrospective claims analysis of managed care members
14. Effects of inhaled corticosteroids on the consequences of asthma
15. Asthma: Benchmarking for quality improvement
16. Current estimates from the National Health Interview Survey 1989. National Center for Health Statistics
17. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization, and death from asthma over two decades: 1965-1984
18. Seasonal trends in US asthma hospitalizations and mortality
19. Preventive pharmacologic therapy among asthmatics: Five years after publication of guidelines
20. Variations in pediatric hospitalization rates: Why do they occur?
21. A community-based study of the epidemiology of asthma
22. Poverty, race, and medication use are correlates of asthma hospitalization rotes. A small area analysis in Boston
23. National hospital discharge survey: Annual summary - Series 13, 1996
24. Diagnostic accuracy of asthma within a health maintenance organization
25. Assessment of asthma using automated and full-text medical records
26. Inhaled steroids and the risk of hospitalization for asthma
27. Antihistamine-associated sudden death, ventricular arrhythmias, syncope and QT-interval prolongation: A comparison of terfenadine and other antihistamines
28. Harvard Community Health Plan
29. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization
30. Predictors of chronic benzodiazepine use in a health maintenance organization sample
31. Trends in pediatric asthma hospitalization rates: Regional and socioeconomic differences
32. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma